[老年CLL患者的第一线治疗:一种创新的无化疗方法]
Deutsche medizinische Wochenschrift (1946)
|October 10, 2025
概括
针对性疗法在慢性淋巴细胞白血病 (CLL) 中比化疗免疫疗法更有效. 遗传因素和患者的健康状况现在指导了第一线治疗选择,特别是在老年人中.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 向疗法在慢性淋巴细胞白血病 (CLL) 的疗效方面已经超过了化疗免疫疗法.
- 新型向药物表现出良好的耐受性,改变了治疗选择标准.
- 遗传因素 (del(17p13) /TP53突变,复杂的型,未变异的IGHV) 现在是第一线治疗决策的关键决定因素.
研究的目的:
- 概述目前针对CLL的向治疗的现状.
- 强调遗传因素在指导一线治疗选择中的作用.
- 强调个性化治疗的重要性,考虑到患者的健康状况和偏好.
主要方法:
- 审查当前的向疗法及其在CLL中的疗效.
- 对影响治疗决策的遗传因素的分析.
- 在选择治疗时考虑老年病人的评估和患者的偏好.
主要成果:
- 与化疗免疫疗法相比,向疗法提供了更优质,更持久的反应.
- 高风险的遗传特征 (del(17p13) /TP53突变,复杂的型,未变异的IGHV) 对于风险分层至关重要.
- 个性化治疗计划,包括并发症,老年评估和患者偏好,可以改善结果,特别是在老年/脆弱的患者中.
结论:
- 基因分析和全面的患者评估对于最佳的第一线CLL治疗至关重要.
- 针对性药物提供了一种更耐受和更有效的方法,特别是在脆弱的患者群体.
- 以患者为中心的决策,平衡疗效和耐受性,对于管理CLL至关重要.
相关概念视频
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K